Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure-Reference-Cited by-同舟云学术

Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure

Published:2003-04 Issue:4 Volume:169 Page:1320-1324
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

D’AMICO ANTHONY V.¹,COTE KERRI¹,LOFFREDO MARIAN¹,RENSHAW ANDREW A.¹,CHEN MING-HUI¹

Affiliation:

1. From the Departments of Radiation Oncology and Pathology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, and Department of Statistics, University of Connecticut, Storrs, Connecticut

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer;Kattan;J Natl Cancer Inst,1998

2. Combined-modality staging for localized adenocarcinoma of the prostate;D'Amico;Oncology,2001

3. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy;Graefen;J Clin Oncol,2002

4. Validation study of the postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer;Graefen;J Clin Oncol,2002

5. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE;Grossfeld;Urology,2002

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy;International Urology and Nephrology;2023-04-05

2. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database;BMC Urology;2022-11-16

3. The importance of personalized medicine in urological cancers;Journal of Diabetes & Metabolic Disorders;2021-06-29

4. Kallikrein gene family as biomarkers for recurrent prostate cancer;Croatian Medical Journal;2020-10

5. Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer–A Pilot Study;Academic Radiology;2020-10